Cargando…

S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL

BACKGROUND: Motivational deficits seem to be one of the main barriers in the recovery process among psychosis patients and have been shown to be very treatment resistant. Motives are conscious and unconscious affect-based needs that influence behavior toward specific incentives. Thus, they constitut...

Descripción completa

Detalles Bibliográficos
Autores principales: Horisberger, Rahel, Kaiser, Stefan, Hartmann, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234232/
http://dx.doi.org/10.1093/schbul/sbaa031.102
_version_ 1783535717992890368
author Horisberger, Rahel
Kaiser, Stefan
Hartmann, Matthias
author_facet Horisberger, Rahel
Kaiser, Stefan
Hartmann, Matthias
author_sort Horisberger, Rahel
collection PubMed
description BACKGROUND: Motivational deficits seem to be one of the main barriers in the recovery process among psychosis patients and have been shown to be very treatment resistant. Motives are conscious and unconscious affect-based needs that influence behavior toward specific incentives. Thus, they constitute the basis of motivated behavior or the lack thereof. In this study, we investigated how individual differences in social motives relate to the phenomenology of motivational negative symptoms in patients with schizophrenia. METHODS: Fifty-nine patients with a diagnosis of schizophrenia were included into the sample. Negative symptoms were measured with the Brief Negative Symptom Scale and social motives with the Questionnaire for the Zurich Model of Social Motivation. Between-group differences, Pearson correlations and regression analysis were calculated. We replicated and extended the results in a second sample of forty-five psychosis patients, using the same methods. RESULTS: A comparison of healthy controls and schizophrenia patients revealed significant differences in social motives. Within the patient group, relationships between the characteristics of the individual motives, in particular the achievement motive, and the severity of the motivational negative symptoms, i.e. of asociality, avolition and anhedonia, could be described. In contrast, social motives cannot be associated with diminished expression, the non-motivational dimension of negative symptoms. The duration of the disease seems to be an additional influencing factor: When comparing the motivational dispositions of first episode patients with those of healthy people, no differences were found. However, a relationship between the duration of the disease and the characteristics of social motives can be described. DISCUSSION: Explicit social motives stand in a relationship with motivational negative symptoms. Since implicit and explicit motives may diverge, the aim of our future research is to additionally investigate the association with implicit motives. The inclusion of psychological factors helps to extend and improve psychotherapeutic interventions for psychosis patients. Since negative symptoms do not respond well to pharmacotherapy, further efforts in this direction are needed to understand the underlying mechanisms of this disease and to develop effective psychotherapy tools in the future.
format Online
Article
Text
id pubmed-7234232
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72342322020-05-23 S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL Horisberger, Rahel Kaiser, Stefan Hartmann, Matthias Schizophr Bull Poster Session I BACKGROUND: Motivational deficits seem to be one of the main barriers in the recovery process among psychosis patients and have been shown to be very treatment resistant. Motives are conscious and unconscious affect-based needs that influence behavior toward specific incentives. Thus, they constitute the basis of motivated behavior or the lack thereof. In this study, we investigated how individual differences in social motives relate to the phenomenology of motivational negative symptoms in patients with schizophrenia. METHODS: Fifty-nine patients with a diagnosis of schizophrenia were included into the sample. Negative symptoms were measured with the Brief Negative Symptom Scale and social motives with the Questionnaire for the Zurich Model of Social Motivation. Between-group differences, Pearson correlations and regression analysis were calculated. We replicated and extended the results in a second sample of forty-five psychosis patients, using the same methods. RESULTS: A comparison of healthy controls and schizophrenia patients revealed significant differences in social motives. Within the patient group, relationships between the characteristics of the individual motives, in particular the achievement motive, and the severity of the motivational negative symptoms, i.e. of asociality, avolition and anhedonia, could be described. In contrast, social motives cannot be associated with diminished expression, the non-motivational dimension of negative symptoms. The duration of the disease seems to be an additional influencing factor: When comparing the motivational dispositions of first episode patients with those of healthy people, no differences were found. However, a relationship between the duration of the disease and the characteristics of social motives can be described. DISCUSSION: Explicit social motives stand in a relationship with motivational negative symptoms. Since implicit and explicit motives may diverge, the aim of our future research is to additionally investigate the association with implicit motives. The inclusion of psychological factors helps to extend and improve psychotherapeutic interventions for psychosis patients. Since negative symptoms do not respond well to pharmacotherapy, further efforts in this direction are needed to understand the underlying mechanisms of this disease and to develop effective psychotherapy tools in the future. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7234232/ http://dx.doi.org/10.1093/schbul/sbaa031.102 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Session I
Horisberger, Rahel
Kaiser, Stefan
Hartmann, Matthias
S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL
title S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL
title_full S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL
title_fullStr S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL
title_full_unstemmed S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL
title_short S36. TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA WITH A MOTIVE-SPECIFIC INTERVENTION: A RANDOMIZED BRIEF INTERVENTION TRIAL
title_sort s36. treating negative symptoms of schizophrenia with a motive-specific intervention: a randomized brief intervention trial
topic Poster Session I
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7234232/
http://dx.doi.org/10.1093/schbul/sbaa031.102
work_keys_str_mv AT horisbergerrahel s36treatingnegativesymptomsofschizophreniawithamotivespecificinterventionarandomizedbriefinterventiontrial
AT kaiserstefan s36treatingnegativesymptomsofschizophreniawithamotivespecificinterventionarandomizedbriefinterventiontrial
AT hartmannmatthias s36treatingnegativesymptomsofschizophreniawithamotivespecificinterventionarandomizedbriefinterventiontrial